Skip to main content
. 2020 Nov 2;63(23):14151–14183. doi: 10.1021/acs.jmedchem.0c00766

Figure 8.

Figure 8

Development by AstraZeneca of ATM inhibitor from hit 22 into candidate AZD1390 (29) through the lead AZD156 (28).